UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million

UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million

Company Secures $20 Million Funding Commitment to Advance Aerospace & Defense Initiatives WEWAHITCHKA-PORT ST JOE, Fla., January 8, 2025 - PRISM MediaWire - UAV Corp (OTC: UMAV), a leader in innovative manned and unmanned aerial vehicle (UAV) technologies, is...

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms eligibility for billing under current Local...